Feline IL-18 proteins
View Patent ↗The present invention relates to canine and feline proteins. In particular, the present invention discloses feline interleukin-18, feline caspase-1, feline interleukin-12 single chain and canine interleukin-12 single chain proteins. The present invention also includes feline interleukin-18, feline caspase-1, feline interleukin-12 single chain and canine interleukin-12 single chain nucleic acid molecules encoding such proteins, antibodies raised against such proteins and/or inhibitors of such proteins or nucleic acid molecules. The present invention also includes therapeutic compositions comprising such nucleic acid molecules, proteins, antibodies and/or inhibitors, as well as their use to evaluate and regulate an immune response in an animal.
1. An isolated protein comprising an amino acid sequence at least 95% identical to a polypeptide sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:5, SEQ ID NO:8 and SEQ ID NO:12,
wherein said protein has IL-18 activity.
2. The isolated protein of claim 1 , wherein said protein comprises SEQ ID NO:2, SEQ ID NO:5, SEQ ID NO:8 or SEQ ID NO:12.
3. An isolated protein encoded by
a nucleic acid sequence at least 95% identical to SEQ ID NO:1, SEQ ID NO:4, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:11, and SEQ ID NO:41,
wherein said isolated protein has IL-18 activity.
4. The isolated protein of claim 3 , wherein said protein is encoded by a nucleic acid sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:4, SEQ ID NO:7, SEQ ID NO:9, SEQ ID NO:11, and SEQ ID NO:41.
5. An isolated protein consisting of an amino acid sequence at least 95% identical to a polypeptide sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:5, SEQ ID NO:8 and SEQ ID NO:12, wherein said protein has IL-18 activity.
6. The isolated protein of claim 5 , wherein the protein consists of an amino acid sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:5, SEQ ID NO:8 and SEQ ID NO:12.